What Is an EHCP and Can It Help with Autism Support in London?

Families navigating autism support in London often encounter the term Education Health and Care Plan (EHCP). But what exactly is an EHCP, who qualifies, and how can it help your child? This post breaks down the statutory duties behind EHCPs, clarifies important distinctions between autism and co-occurring conditions, highlights relevant NICE guidance, and points out key considerations when pursuing funding requests.

Understanding the Education Health and Care Plan (EHCP)

An EHCP is a legal document provided by local authorities in England under the Children and Families Act 2014. It outlines a child or young person’s education, health, and social care needs and the support required to meet those needs up to age 25. This is especially significant for children with special educational needs and disabilities (SEND), including those diagnosed with autism spectrum disorder (ASD).

EHCPs replace the older system of Statements of Special Educational Needs and are designed to put a child’s holistic requirements at the heart of planning and funding. It’s important to know that requesting an EHCP triggers statutory duties on local authorities to assess and, if applicable, provide support.

Who Qualifies for an EHCP?

Not every child with autism automatically gets an EHCP. The threshold depends on the severity and complexity of their needs, and the level of support already available through mainstream settings or short-term interventions. The EHCP assessment considers whether:

Current educational and health provision meets the child’s needs
Additional or different support is required to make progress
The child faces multiple challenges that interfere substantially with learning and social participation

London families often report variation between boroughs in assessment criteria and timelines, so persistence and thorough documentation are key.

Autism vs. Co-occurring Conditions: Why Differentiation Matters

Autism is a neurodevelopmental condition defined primarily by difficulties with social communication and restrictive, repetitive behaviors. However, many autistic children also experience co-occurring conditions such as epilepsy, anxiety, or attention deficit hyperactivity disorder (ADHD). When applying for an EHCP or other services, it’s critical to differentiate which needs stem from autism itself and which arise from these associated conditions.

This distinction matters because:

Some interventions and statutory supports target autism-related difficulties specifically
Co-occurring conditions often require separate health or therapeutic interventions governed by different clinical guidelines
Funding requests must clearly justify how each identified need hampers education or social inclusion

For example, epilepsy associated with autism may influence EHCP health provision but follows stringent clinical pathways. The National Institute https://londoninsider.co.uk/medical-cannabis-and-autism-what-london-families-should-know/ for Health and Care Excellence (NICE) provides valuable condition-specific guidance, which should inform plans.

NICE Guidance and Its Role in Autism Support

The NICE guidance library offers evidence-based recommendations covering health and social care in England. For autism, NICE’s 2013 guideline (updated 2021) focuses on supporting social communication, behavior, and mental health. It discourages unproven or harmful treatments and encourages personalized support plans.

What NICE Does NOT Recommend for Autism

It’s crucial to note that NICE explicitly advises against the use of certain unregulated therapies, including:

Any interventions claiming to “cure” autism
Standard use of cannabis-based products for autism itself (except in approved clinical trials for specific co-occurring conditions)
Non-evidence-based behavioral approaches that lack structured measurement

The NICE guideline CG170 helps clinicians and educators avoid "hand-wavy" outcomes such as reports your child "seems calmer" without objective evaluation.

Epilepsy in Autism: Narrow Indications for Certain Treatments

Some children with autism have epilepsy — a co-occurring condition that can severely impact learning and health. Here, NICE’s epilepsy guidelines clarify indications for drug treatments:

Epilepsy Type Treatment Mentioned Notes Dravet syndrome Cannabidiol (CBD) - Epidyolex Licensed only for Dravet or Lennox-Gastaut syndromes; requires specialist monitoring Lennox-Gastaut syndrome Cannabidiol (CBD) - Epidyolex Supported by strong clinical evidence; treatment is adjunctive Other epilepsy types No routine use of cannabis-based products recommended Evidence lacking or inconclusive

This narrow treatment window underscores why clear diagnosis and guideline adherence are essential. The General Medical Council (GMC) advises doctors to follow up-to-date NICE guidance to ensure treatments are rational, safe, and legally defensible.

Limitations of Evidence and Placebo Effects in Autism Treatments

When considering any treatment or therapy for autism or co-occurring conditions, understanding evidence quality is fundamental. Much autism research suffers from small sample sizes, subjective outcome measures, and few long-term studies.

Key Points on Evidence

Many interventions show modest benefits with wide individual variability
Placebo effects — where reported improvements relate to expectations rather than specific treatment actions — are common in behavioral trials
Objective, measurable goals and periodic reviews must underpin any support plan

This highlights why EHCPs incorporating multidisciplinary assessments aligned with NICE guidance provide a more reliable pathway than pursuing anecdotal or commercially pushed treatments.

How an EHCP Can Support Autism in London

For families seeking autism support, the EHCP offers a structured means to secure funding and coordinate services across education, health, and social care:

Assessment Strength: Statutory assessments must review comprehensive needs and involve parents, educators, and health professionals.
Tailored Support: Enables bespoke interventions, therapy hours, assistive technology, and social skills programs.
Legal Leverage: Local authorities are legally obliged to provide by the EHCP’s defined provisions, including funding.
Review and Accountability: Annual reviews ensure the plan keeps pace with changing needs.

London boroughs vary, but experienced families often recommend:

Start the EHCP request early if your child’s needs are unmet despite existing support
Document in detail how autism and any co-occurring conditions affect education
Use supporting letters from NHS clinicians referencing NICE-approved interventions
Be prepared for assessments that distinguish autism impacts from other health issues
Engage local SEND information, advice, and support services (IASS) for borough-specific procedures

Conclusion

The Education Health and Care Plan is a vital tool for getting statutory recognition and funding of the complex needs that come with autism, especially when co-occurring conditions like epilepsy add layers of challenge. Supported by NICE guidance and the GMC’s professional standards, EHCPs balance evidence-based care with educational inclusion.

If you’re considering an EHCP request in London, keep the focus on comprehensive needs assessment, clear documentation, and realistic expectations grounded in clinical guidelines. Although the road can be lengthy, the strength of statutory duties ensures that with persistence and informed advocacy, your family can access the support your child deserves.

Useful Resources

NICE official website and guidance library
General Medical Council (GMC) professional standards
Official Government guidance on EHCPs
London SEND Information, Advice and Support Services